Recruiting

Observational Study

Sponsor:

Optos, PLC

Code:

NCT07796230

Conditions

Retina Disease

Eligibility Criteria

Sex: All

Age: 22+

Healthy Volunteers: Accepted

Interventions

imaging device

Study Details

Brief summary:

Images will be collected on the modified P200TE

Conditions

Retina Disease

Study ID

NCT07796230

Start date

Jul 29, 2026

Status verified date

Aug, 2026

Completion date

Oct 1, 2026

Anticipated

Primary completion date

Oct 1, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 22+

Healthy Volunteers: Accepted

Inclusion Criteria

Male or female participants 22 years of age or older who have full legal capacity to volunteer on the date the informed consent is signed

Participants who can follow the instructions by the clinical staff at the clinical site

Participants who agree to participate in the study

Participants with posterior segment eye disease. Example of pathologies may include but are not limited to Age-related macular degeneration, glaucoma, diabetic retinopathy, posterior uveitis, central serous chorioretinopathy, vein occlusion, epiretinal membrane and others as confirmed by the investigator.

Exclusion Criteria

Participants unable to tolerate ophthalmic imaging.

Participants with ocular media not sufficiently clear to obtain acceptable images.

Unable to obtain acceptable image quality on participant.

Study Design

Enrollment

50 participants

Anticipated

Interventions and Outcome Measures

Interventions

imaging device

images captured on a modified P200TE

Primary outcome measure

  • Number of images [ Time Frame: 1 year ]

Central Contacts and Locations

Locations

Bennett & Bloom Eye Centers

Recruiting

Louisville, Kentucky, United States, 40222

Contacts

More Information

Sponsor

Optos, PLC

Last update posted

Sep 1, 2026

Last verified

Aug, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Optos, PLC on 2026-09-01.